Idiopathic thrombocytopenic purpura

Idiopathic thrombocytopenic purpura (ITP), thrombocytopenia that results from immunologic platelet destruction, may be acute (postviral thrombocytopenia) or chronic (Werlhof’s disease, purpura hemorrhagica, essential thrombocytopenia, autoimmune thrombocytopenia). Acute ITP usually affects children between ages 2 and 6; chronic ITP mainly affects adults younger than age 50, especially women between ages 20 and 40.

The prognosis for acute ITP is excellent; nearly four out of five patients recover without treatment. The prognosis for chronic ITP is good; remissions lasting weeks or years are common, especially among women.

Causes

ITP may be an autoimmune disorder because antibodies that reduce the life span of platelets have been found in nearly all patients. The spleen probably helps to remove platelets modified by the antibody. Acute ITP usually follows a viral infection, such as rubella and chickenpox, and can follow immunization with a live virus vaccine. Chronic ITP seldom follows infection and is commonly linked to immunologic disorders, such as systemic lupus erythematosus or human immunodeficiency virus infection. It’s also linked to drug reactions.

Signs and symptoms

Signs and symptoms of ITP common to all forms of thrombocytopenia include petechiae, ecchymoses, and mucosal bleeding from the mouth, nose, and GI tract. Generally, hemorrhage is a rare physical finding. Purpuric lesions may occur in vital organs, such as the lungs, kidneys, or brain, and may prove fatal.

With acute ITP, which is common in children, onset is usually sudden and without warning, causing easy bruising, epistaxis, and bleeding gums. Onset of chronic ITP is insidious.

Diagnosis

Platelet count less than 20,000/µl combined with prolonged bleeding time suggest ITP. Platelet size and morphologic appearance may be abnormal; anemia may be present if bleeding has occurred.

As in thrombocytopenia, bone marrow studies show an abundance of megakaryocytes and a shortened circulating platelet survival time (hours or days). Occasionally, platelet antibodies may be found in vitro, but this diagnosis is usually inferred from platelet survival data and the absence of an underlying disease. The patient’s immunoglobulin G level may also be increased.

Treatment

Acute ITP may be allowed to run its course without intervention or may be treated with a glucocorticoid or immune globulin. For chronic ITP, a corticosteroid may be the initial treatment of choice. Patients who fail to respond within 1 to 4 months or who need high steroid dosage are candidates for splenectomy, which has an 85% success rate. Alternative treatments include immunosuppression, high-dose I.V. gamma globulin, and immunoabsorption apheresis using staphylococcal protein-A columns.

Clinical tip  Before splenectomy, the patient may require blood, blood components, or vitamin K to correct anemia and coagulation defects. After splenectomy, he may need blood and component replacement and platelet concentrate. Normally, platelets increase spontaneously after splenectomy.

The patient may find complementary therapies to be helpful. He may explore such therapies with his physician.

Special considerations

❑ Care for ITP is essentially the same as for other types of thrombocytopenia, with emphasis on teaching the patient to watch for petechiae, ecchymoses, and other signs of recurrence.

❑ If the patient is receiving an immunosuppressant, monitor him for signs of bone marrow depression, infection, mucositis, GI ulcers, and severe diarrhea or vomiting.

❑ Tell the patient to avoid aspirin, ibuprofen, and other nonsteroidal anti-inflammatory drugs.

❑ Encourage the patient to contact the Platelet Disorder Support Association.

Book Source Details

• Book Title: Handbook of Diseases
• Author(s): Springhouse
• Year of Publication: 2003
• Copyright Details: Handbook of Diseases, Copyright © 2003 Lippincott Williams & Wilkins.

Other Book Chapters Related to Hemorrhagic rash

Read excerpts from these other book chapters related to Hemorrhagic rash:

Copyright Details: Handbook of Diseases, Copyright © 2008 Williams & Wilkins.

More About Causes of Hemorrhagic rash

• Back to symptom: Hemorrhagic rash: Introduction (review 7 causes)
• Next Book Extract About Hemorrhagic rash: Skin, mottled (Alarming Signs and Symptoms: Lippincott Manual of Nursing Practice Series)
• All Book Extracts: All Online Book Extracts for Hemorrhagic rash

More About This Book: Title: Handbook of Diseases Authors: Springhouse Publisher: Lippincott Williams & Wilkins Copyright: 2003 ISBN: 1-58255-266-5

 » Next page: Skin, mottled (Alarming Signs and Symptoms: Lippincott Manual of Nursing Practice Series)

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

• Skin, mottled (Alarming Signs and Symptoms: Lippincott Manual of Nursing Practice Series)
• Purpura (Signs & Symptoms: A 2-in-1 Reference for Nurses)
• Skin, mottled (Signs & Symptoms: A 2-in-1 Reference for Nurses)
• Purpura and Bleeding (The Diagnostic Approach to Symptoms and Signs in Pediatrics)
• Purpura (Nursing: Interpreting Signs and Symptoms)

Tools & Services:

• Bookmark this page
• Take a survey relating to Hemorrhagic rash
• Symptom Search
• Symptom Checker
• Medical Dictionary
• Give your feedback

Medical Articles:

• Disease & Treatments Search
• Misdiagnosis Center
• Full list of interesting articles

Forums & Message Boards

• Ask or answer a question at the Boards:
• I cannot get a diagnosis. Please help.
• Tell us your medical story.
• Share your misdiagnosis story.
• What is the best treatment for my condition?
• See all the Boards.

Enter your search terms Submit search form
Search The Web Search wrongdiagnosis.com

Common Health Mistakes

Symptom
Checker

Search Specialists by State and City